Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 127.15M | 118.5M | 115.44M | 126.07M | 145.93M | 103.5M | 181.72M | 108.52M | 135.47M | 168.09M |
Short-Term Investments | 170.02M | 231.88M | 262.89M | 247.21M | 216.69M | 172.6M | 105.11M | 75.51M | 61.68M | 51.48M |
Long-Term Investments | 47.96M | 50.85M | 52.26M | 70.73M | 89.13M | 102.33M | 117.62M | 30.63M | 42.65M | 3M |
Other Long-Term Assets | 16.24M | 9.54M | 9.4M | 9.18M | 9.12M | 8.73M | 8.55M | 8.32M | 7.42M | 6.48M |
Receivables | 3.1M | 2.44M | 1.09M | 2.92M | 3.12M | 2.95M | 10.06M | 11K | 467K | 256K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.15M | 5.82M | 6.18M | 5.47M | 5.67M | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 305.42M | 358.64M | 385.59M | 381.67M | 371.4M | 285.77M | 300.64M | 186.54M | 203.33M | 226M |
Property-Plant & Equipment | 59.11M | 64.32M | 65.88M | 67.37M | 69.78M | 72.19M | 74.32M | 76.28M | 72.52M | 74.28M |
Goodwill & Intangibles | 60.09M | 60.52M | 60.95M | 61.39M | 61.82M | 62.25M | 62.68M | 81.52M | 81.94M | 89.01M |
Total Long-Term Assets | 183.39M | 185.23M | 188.49M | 208.67M | 229.84M | 245.5M | 263.16M | 196.74M | 204.54M | 172.77M |
Total Assets | 488.81M | 543.88M | 574.08M | 590.34M | 601.24M | 531.27M | 563.8M | 383.28M | 407.87M | 398.77M |
Account Payables | 16.36M | 9.77M | 9.75M | 11.84M | 4.91M | 9.04M | 8.58M | 5.51M | 9.22M | 7.36M |
Deferred Revenue | 29.29M | n/a | n/a | n/a | n/a | 12.92M | 17.1M | 13.66M | 10.95M | 14.1M |
Short-Term Debt | 4.27M | 5.08M | 4.95M | 4.81M | 4.7M | 4.58M | 4.4M | 4.19M | 3.28M | 3.13M |
Other Current Liabilities | 2.56M | 36.1M | 36.14M | 28.08M | 19.87M | 10.03M | 10M | 210K | 321K | 383K |
Total Current Liabilities | 52.47M | 50.96M | 50.84M | 44.74M | 29.48M | 36.57M | 40.09M | 23.57M | 23.77M | 24.98M |
Long-Term Debt | 29.72M | 33.18M | 34.49M | 35.76M | 37.17M | 38.46M | 39.59M | 40.76M | 37.15M | 37.97M |
Other Long-Term Liabilities | 44.51M | 42.26M | 41.74M | 34.47M | 26.73M | 28.71M | 29.75M | 34M | 34.58M | 18.93M |
Total Long-Term Liabilities | 79.3M | 80.52M | 81.31M | 70.96M | 64.63M | 67.91M | 70.08M | 89.93M | 87.37M | 73.27M |
Total Liabilities | 131.77M | 131.48M | 132.14M | 115.7M | 94.11M | 104.47M | 110.16M | 113.5M | 111.14M | 98.25M |
Total Debt | 33.98M | 38.26M | 39.44M | 40.57M | 41.87M | 43.04M | 43.99M | 44.96M | 40.43M | 41.1M |
Common Stock | 7K | 7K | 7K | 6K | 6K | 6K | 5K | 4K | 4K | 4K |
Retained Earnings | -546.75M | -479.81M | -419.63M | -357.08M | -301.1M | -263.45M | -231.77M | -239.31M | -208.62M | -166.04M |
Comprehensive Income | -1.32M | -1.71M | -3.16M | -3.62M | -2.53M | -1.54M | -55K | 373K | 172K | 65K |
Shareholders Equity | 357.04M | 412.39M | 441.94M | 474.64M | 507.13M | 426.8M | 453.64M | 269.78M | 296.73M | 300.52M |
Total Investments | 211.22M | 273.08M | 315.15M | 317.94M | 305.82M | 274.93M | 222.73M | 106.14M | 104.34M | 54.48M |